Skip to content
Close
Customers
Biopharma
MedTech
Payers & Providers
Government
Products
Software Overview
Discover
Substantiate
Data Powered Offerings
Generate
Services
Regulatory & Scientific Services
Data Services
Company
About Us
Regulatory Partnerships
Leadership
Careers
Resources
News
Evidence Hub
Events
CARE Initiative
SEARCH
Let's Talk
Customers
Biopharma
MedTech
Payers & Providers
Government
Products
Software Overview
Discover
Substantiate
Data Powered Offerings
Generate
Services
Regulatory & Scientific Services
Data Services
Company
About Us
Regulatory Partnerships
Leadership
Careers
Resources
News
Evidence Hub
Events
CARE Initiative
Let's Talk
Quick results for "{search_term}"
Admin
Apr 12, 2021
< 1 min read
ICER launches pilot program to update past assessments using real-world data
Previous
Next
Jazz Pharmaceuticals has received priority review from the FDA for expanding the use of Xywav in adult idiopathic hypersomnia patients. This comes after an eight and a half month gap since the drug's last approval.
Read More
Admin
RELATED ARTICLES
